Alpha 2.0
Login Register
» Authors » Osten Ljunggren

Osten Ljunggren

Explore the profile of Osten Ljunggren including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 146
Citations 6357
Followers 0
Related Specialties
Endocrinology
General Medicine
Genetics
Top 10 Co-Authors
Dan Mellstrom
Claes Ohlsson
Magnus K Karlsson
Mattias Lorentzon
Liesbeth Vandenput
Eric Orwoll
Andreas Kindmark
Magnus Karlsson
Hans Mallmin
Elin Grundberg
Published In
J Bone Miner Res
J Clin Endocrinol Metab
Lakartidningen
Bone
PLoS Genet
Affiliations
Soon will be listed here.
Recent Articles
1.
Fracture Incidence in Graves' Disease: A Population-Based Study
Khamisi S, Udumyan R, Sjolin G, Calissendorff J, Filipsson Nystrom H, Holmberg M, et al.
Thyroid . 2023 Sep; 33(11):1349-1357. PMID: 37725590
Population-based studies have indicated an increase in bone turnover in hyperthyroidism with a subsequent decrease in bone mineral density and an increased risk of fractures, especially in postmenopausal women. However,...
2.
3D Finite Element Models Reconstructed From 2D Dual-Energy X-Ray Absorptiometry (DXA) Images Improve Hip Fracture Prediction Compared to Areal BMD in Osteoporotic Fractures in Men (MrOS) Sweden Cohort
Grassi L, Vaananen S, Jehpsson L, Ljunggren O, Rosengren B, Karlsson M, et al.
J Bone Miner Res . 2023 Jul; 38(9):1258-1267. PMID: 37417707
Bone strength is an important contributor to fracture risk. Areal bone mineral density (aBMD) derived from dual-energy X-ray absorptiometry (DXA) is used as a surrogate for bone strength in fracture...
3.
Increased plasma levels of soluble programmed death ligand 1 (sPD-L1) and fibroblast growth factor 23 (FGF-23) in patients with Graves' ophthalmopathy in comparison to hyperthyroid patients without Graves' ophthalmopathy
Khamisi S, Anders Karlsson F, Ljunggren O, Thulin M, Larsson A
Cytokine . 2023 Jun; 169:156269. PMID: 37307688
Background: Management of Graves' ophthalmopathy (GO) is still a challenge in Graves' disease (GD). Moreover, 40% of GD patients show radiological muscle enlargement without clinically apparent GO. Delayed treatment of...
4.
Comparison Between Thyroid Stimulating Immunoglobulin and TSH-Receptor Antibodies in the Management of Graves' Orbitopathy
Khamisi S, Lundqvist M, Engstrom B, Larsson A, Anders Karlsson F, Ljunggren O
Exp Clin Endocrinol Diabetes . 2023 Jan; 131(4):236-241. PMID: 36706788
Objectives: TSH-receptor antibodies (TRAb) targeting the TSH receptor (TSH-R) induce hyperthyroidism in Graves´ disease (GD). Graves´ orbitopathy (GO) is influenced by stimulation of the TSH-R in the orbita. GO has...
5.
The association between peripheral arterial disease and risk for hip fractures in elderly men is not explained by low hip bone mineral density. Results from the MrOS Sweden study
Bokrantz T, Manhem K, Lorentzon M, Karlsson M, Ljunggren O, Ohlsson C, et al.
Osteoporos Int . 2022 Aug; 33(12):2607-2617. PMID: 35986119
Introduction: To examine if peripheral arterial disease (PAD) is associated with an increased risk for hip fracture in men independent of hip BMD. Methods: Ankle-brachial index (ABI) was assessed in...
6.
Novel Biomarkers Detected by Proteomics Predict Death and Cardiovascular Events in Hemodialysis Patients
Wu P, Glerup R, Svensson M, Eriksson N, Christensen J, Laval P, et al.
Biomedicines . 2022 Apr; 10(4). PMID: 35453489
End-stage kidney disease increases mortality and the risk of cardiovascular (CV) disease. It is crucial to explore novel biomarkers to predict CV disease in the complex setting of patients receiving...
7.
Complications and adverse effects related to surgical and medical treatment in patients with inflammatory bowel disease in a prospectively recruited population-based cohort
Ronnblom A, Ljunggren O, Karlbom U
Scand J Gastroenterol . 2021 Aug; 56(11):1296-1303. PMID: 34369245
Background: Medical adverse effects and surgical complications have been reported during treatment of patients with inflammatory bowel diseases (IBDs). There is however a shortage of studies describing these in the...
8.
Serum Glycine Levels Are Associated With Cortical Bone Properties and Fracture Risk in Men
Eriksson A, Friedrich N, Karlsson M, Ljunggren O, Lorentzon M, Nethander M, et al.
J Clin Endocrinol Metab . 2021 Jul; 106(12):e5021-e5029. PMID: 34297085
Context: In a recent study a pattern of 27 metabolites, including serum glycine, associated with bone mineral density (BMD). Objective: To investigate associations for serum and urinary glycine levels with...
9.
What Cut-Point in Gait Speed Best Discriminates Community-Dwelling Older Adults With Mobility Complaints From Those Without? A Pooled Analysis From the Sarcopenia Definitions and Outcomes Consortium
Cawthon P, Patel S, Kritchevsky S, Newman A, Santanasto A, Kiel D, et al.
J Gerontol A Biol Sci Med Sci . 2021 Jun; 76(10):e321-e327. PMID: 34166490
Background: Cut-points to define slow walking speed have largely been derived from expert opinion. Methods: Study participants (13 589 men and 5043 women aged ≥65years) had walking speed (m/s) measured...
10.
Osteoprotegerin predicts cardiovascular events in patients treated with haemodialysis
Wu P, Glerup R, Svensson M, Eriksson N, Christensen J, Linde T, et al.
Nephrol Dial Transplant . 2021 Jun; 37(6):1162-1170. PMID: 34086939
Background: Disturbances in bone mineral metabolism are associated with increased mortality and cardiovascular events (CVEs). However, the association between bone-associated protein biomarkers, mortality and CVEs independent of cytokine activation remains...